WSJ explores potential impact of biosimilars on biotech drug market
The Wall Street Journal is examining the potential that biosimilars can have in the market for biotechnology drugs by looking at how they have been received in Europe to highlight their potential in the U.S. following the launch of Zarxio, the first U.S. biosimilar, earlier this month.
Camber launches generic Nexium
PISCATAWAY, N.J. — Camber Pharmaceuticals on Wednesday announced the launch of its generic version of Nexium (esomeprazole magnesium) delayed-release capsules. The launch comes after Camber’s parent company, Hetero Labs received final approval from the Food and Drug Administration.
“Esomeprazole represents another very significant product in the growth of our organization, Camber president Kon Ostaficiuk said. “We are happy that patients have a more affordable treatment option.”
The drug is meant to treat heartburn, stomach ulcers, gastroesophageal reflux disease, and a damaged esophagus. It will be available in 20- and 40-mg capsules, both of which will be available in bottles of 30, 90 and 1000.
Calif. pharmacy board provides Rx support to wildfire evacuees
SACRAMENTO, Calif. — As both the Butte and Valley Fire raged in northern California, the state’s board of pharmacy held an emergency meeting to ensure that those affected by the blazes have access to medications. Last week, the board waived certain regulations for pharmacists in 18 counties containing and adjacent to the fire, allowing pharmacists to dispense medication to evacuees, even if their prescriptions aren’t on file with a particular pharmacy.
The move came as the two fires — which are slowly being contained and have collectively destroyed nearly 2,000 structures, burned more than 146,000 acres and killed two — forced thousands of people out of their homes and California Gov. Jerry Brown declared a state of emergency.
The emergency waiver allows pharmacists to dispense a 30-day supply of medically necessary drugs to a patient or pet, even without a prescription or empty container, excepting sterile compounded prescriptions and controlled substances. The waiver will stay in place until the state of emergency is lifted, California’s board of pharmacy said.